CS logo
small CS logo
S.C Oncocenter Oncologie Clinica S.R.L

Timisoara, Romania
Private hospital in Timișoara
Strada Gării 1A, Timișoara

About S.C Oncocenter Oncologie Clinica S.R.L


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
4
EMD Serono Research & Development Institute, Inc.
3
Pfizer
2
Boehringer Ingelheim
1
Can-Fite BioPharma
1
Celgene
1
Debiopharm International SA
1
Eisai Inc.
1
Five Prime Therapeutics, Inc.
1
Incyte Corporation
1
Total Rows: 10

Clinical Trials at S.C Oncocenter Oncologie Clinica S.R.L


During the past decade, S.C Oncocenter Oncologie Clinica S.R.L conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 11 clinical trials were completed, i.e. on average, 68.8% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 9 clinical trials were completed. i.e. 900% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years770022224400000011000000111122332222Started TrialsCompleted Trails20152016201720182019202020212022202302468
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Phase III Trial BI 695502 Plus Chemotherapy vs. Avastin® Plus Chemotherapy in Patients With Lung Cancer
2015-07-08
2018-11-16
Completed
671
Avelumab in Non-Small Cell Lung Cancer (JAVELIN Lung 200)
2015-03-24
2019-12-03
Completed
792
A Study of Atezolizumab (MPDL3280A) Compared With a Platinum Agent (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Participants With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower110]
2015-07-20
2022-03-08
Completed
572
Safety And Efficacy Study Of Palbociclib Plus Cetuximab Versus Cetuximab To Treat Head And Neck Cancer
2015-09-10
2022-09-16
Completed
124
Avelumab in First-line NSCLC (JAVELIN Lung 100)
2015-10-29
2022-12-31
Active, not recruiting
1,214
Phase 3 Study on the Efficacy and Safety of Tanezumab in Patients With Cancer Pain Due to Bone Metastasis Who Are Taking Background Opioid Therapy
2015-10-28
2021-06-25
Completed
156
Avelumab in First-Line Maintenance Gastric Cancer (JAVELIN Gastric 100)
2015-12-24
2021-06-03
Completed
499
Trial to Assess Safety and Efficacy of Lenvatinib (18 mg vs. 14 mg) in Combination With Everolimus in Participants With Renal Cell Carcinoma
2017-08-17
2023-08-31
Active, not recruiting
343

Rows per page:

1–16 of 16

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "S.C Oncocenter Oncologie Clinica S.R.L" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "EMD Serono Research & Development Institute, Inc." with 3 trials sponsored, "Pfizer" with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Can-Fite BioPharma" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "S.C Oncocenter Oncologie Clinica S.R.L" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 3 trials as a collaborator, "BeiGene" with 1 trials as a collaborator, "Caris Life Sciences" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Foundation Medicine, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.
Created with Highcharts 11.1.0Top Leading SponsorsHoffmann-La Roche: 4Hoffmann-La Roche: 4EMD Serono Research &Development Institute,Inc.: 3EMD Serono Research &Development Institute,Inc.: 3Pfizer: 2Pfizer: 2Boehringer Ingelheim: 1Boehringer Ingelheim: 1Can-Fite BioPharma: 1Can-Fite BioPharma: 1Celgene: 1Celgene: 1Debiopharm International SA: 1Debiopharm International SA: 1Eisai Inc.: 1Eisai Inc.: 1Five Prime Therapeutics, Inc.: 1Five Prime Therapeutics, Inc.: 1Incyte Corporation: 1Incyte Corporation: 1

Created with Highcharts 11.1.0Top CollaboratorsMerck KGaA,Darmstadt, Germany: 3Merck KGaA,Darmstadt, Germany: 3BeiGene: 1BeiGene: 1Caris Life Sciences: 1Caris Life Sciences: 1Eli Lilly and Company: 1Eli Lilly and Company: 1Foundation Medicine, Inc.: 1Foundation Medicine, Inc.: 1Merck Sharp & Dohme LLC: 1Merck Sharp & Dohme LLC: 1Optimal Research (JustIn Time sites): 1Optimal Research (JustIn Time sites): 1Zai Lab (Shanghai) Co., Ltd.: 1Zai Lab (Shanghai) Co., Ltd.: 1

Clinical Trials Conditions at S.C Oncocenter Oncologie Clinica S.R.L


According to Clinical.Site data, the most researched conditions in "S.C Oncocenter Oncologie Clinica S.R.L" are "Carcinoma, Non-Small-Cell Lung" (3 trials), "Hepatocellular Carcinoma" (2 trials), "Non-Small Cell Lung Cancer" (2 trials), "Bone Metastasis" (1 trials) and "Cancer Pain" (1 trials). Many other conditions were trialed in "S.C Oncocenter Oncologie Clinica S.R.L" in a lesser frequency.

Clinical Trials Intervention Types at S.C Oncocenter Oncologie Clinica S.R.L


Most popular intervention types in "S.C Oncocenter Oncologie Clinica S.R.L" are "Drug" (16 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Gemcitabine" (4 trials), "Placebo" (4 trials), "Avelumab" (3 trials), "Carboplatin" (3 trials) and "Cisplatin" (3 trials). Other intervention names were less common.

Clinical Trials Genders at S.C Oncocenter Oncologie Clinica S.R.L


The vast majority of trials in "S.C Oncocenter Oncologie Clinica S.R.L" are 16 trials for "All" genders.

Clinical Trials Status at S.C Oncocenter Oncologie Clinica S.R.L


Currently, there are NaN active trials in "S.C Oncocenter Oncologie Clinica S.R.L". 1 are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in S.C Oncocenter Oncologie Clinica S.R.L, undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in S.C Oncocenter Oncologie Clinica S.R.L, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 9Phase 3: 9Phase 2: 6Phase 2: 6

Created with Highcharts 11.1.0Trials StatusCompleted: 8Completed: 8Active, not recruiting: 4Active, not recruiting: 4Terminated: 2Terminated: 2Not yet recruiting: 1Not yet recruiting: 1Recruiting: 1Recruiting: 1